I-MAB (IMAB)
1.66
-0.08
(-4.60%)
USD |
NASDAQ |
May 31, 16:00
1.66
0.00 (0.00%)
After-Hours: 20:00
I-MAB Total Liabilities (Quarterly): 126.23M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 126.23M |
June 30, 2023 | 146.81M |
June 30, 2023 | 146.81M |
December 31, 2022 | 168.68M |
June 30, 2022 | 145.56M |
June 30, 2022 | 145.56M |
December 31, 2021 | 163.42M |
June 30, 2021 | 106.47M |
June 30, 2021 | 106.47M |
Date | Value |
---|---|
December 31, 2020 | 108.16M |
September 30, 2020 | 81.51M |
June 30, 2020 | 48.63M |
June 30, 2020 | 48.63M |
December 31, 2019 | 539.14M |
September 30, 2019 | 77.15M |
June 30, 2019 | 494.61M |
June 30, 2019 | 494.61M |
December 31, 2018 | 484.23M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
48.63M
Minimum
Jun 2020
539.14M
Maximum
Dec 2019
185.20M
Average
145.56M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
Verastem Inc | 77.32M |
Summit Therapeutics Inc | 132.57M |
CEL-SCI Corp | 15.74M |
AIM ImmunoTech Inc | 11.36M |
IGC Pharma Inc | 2.206M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 368.62M |
Shareholders Equity (Quarterly) | 242.38M |
Debt to Equity Ratio | 0.0517 |
Current Ratio | 5.674 |
Net Debt Paydown Yield | -2.73% |